search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
133 new news items in the last 24 hours
  1. Home
  2. International

The US Department of Health has announced that it is abandoning the development of mRNA vaccines and focusing on a universal cancer vaccine.

Gabriel Dumitrache
whatsapp
facebook
linkedin
x
copy-link copy-link
6 August 2025, 05:27
main event image
International
Tom Williams / AP / Profimedia
google-preference

Always see our news on Google

The HHS, led by Robert F. Kennedy Jr. has decided to abandon development of mRNA vaccines, including a contract with Moderna for an avian flu vaccine, affecting 22 projects worth nearly $500 million. At the same time, researchers at the University of Florida have obtained promising results for an experimental mRNA vaccine that stimulates the immune system to fight cancer without targeting a specific protein. This suggests a new paradigm in the development of cancer vaccines, with the potential to offer innovative treatments for various types of tumors.

Sources

sursa imagine
Digi24
Departamentul Sănătăţii condus de Robert F. Kennedy jr. renunţă la finanţarea dezvoltării vaccinurilor cu tehnologia ARNm
sursa imagine
Politico Europe
US to halt $500M in vaccine projects
sursa imagine
BBC
RFK Jr cancels $500m in mRNA vaccine development in the US
sursa imagine
The Guardian EU
RFK Jr's health department to halt $500m in mRNA vaccine research
sursa imagine
Le Monde
Robert Kennedy Jr, le ministre de la santé américain, bloque les financements pour les vaccins à ARN messager
sursa imagine
NBC News
RFK Jr. cuts $500 million in mRNA vaccine contracts
sursa imagine
independent.co.uk
RFK Jr cancels $500M in vaccine development after ‘listening to the experts’
sursa imagine
FOX News
RFK Jr cancels $500 million in mRNA research, HHS to prioritize 'safer' vaccine alternatives
sursa imagine
News.ro
Departamentul Sănătăţii condus de Robert F. Kennedy jr. renunţă la finanţarea dezvoltării vaccinurilor cu tehnologia ARNm

Latest News

23:00

London authorities close traffic on Oxford Street: Britain’s busiest shopping street becomes pedestrian-only

22:55

Meta seeks to raise up to $95 billion to expand its artificial intelligence infrastructure

22:47

Audi CEO criticized in Germany after appearing alongside Trump / Gernot Döllner participated in the announcement of a $4.2 billion investment to build Audi’s first factory in the US

22:39

Kelemen Hunor estimates that the Luca Niculescu Government will remain in power until 2028: “If nobody brings you down, then you have no choice, you are condemned to govern”

22:33

Microsoft offers voluntary departures to approximately 60,000 employees across four countries amid massive investments in artificial intelligence

See more news

NEWS ON THE SAME TOPICS

event image
International
An experimental cancer vaccine, developed by Moderna and Merck, has shown promising results in patients with melanoma.
event image
Health
Moderna and Merck announce promising results for the personalized vaccine against melanoma recurrence
event image
Health
The pharmaceutical group Minapharm will develop a candidate vaccine against the Bundibugyo Ebola strain, with funding of 16.5 million dollars.
event image
EU
Commission makes Sanofi’s commitments on communications about rival flu vaccine Fluad binding
event image
Health
The U.S. Food and Drug Administration has approved a drug that doubles the survival rate of patients with advanced pancreatic cancer.
event image
International
Donald Trump signs a decree with new recommendations regarding vaccination, which calls for the vaccination of children to be reduced.
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
HHS the united states department of health Robert F Kennedy Jr USA vaccination modern mRNA

Editor’s Recommendations

main event image
Exclusive
11 hours ago

ANALYSIS Midterms: Trump, the unpredictable variable. Why Democrats cannot rely on the optimism of the polls

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol